In summary, PTX3 inhibition can reduce LPS-induced liver injury through promoting hepatocyte ferroptosis and M1-type macrophage recruitment in sepsis (Fig. 6), which suggests that PTX3 might be a novel regulator involved in the treatment of bacterial infections. This evidence concerns the gene PTX3 and bacterial infectious disease.